Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations
Ramu Anandakrishnan, Robin Varghese, Nicholas A. Kinney, et al.
PLoS Computational Biology (2019) Vol. 15, Iss. 3, pp. e1006881-e1006881
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo , in Vitro , and in Silico Data
Jennifer E. Kay, Julia Green Brody, Megan R. Schwarzman, et al.
Environmental Health Perspectives (2024) Vol. 132, Iss. 1
Open Access | Times Cited: 18
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution
Yelyzaveta Shlyakhtina, Katherine L. Moran, Maximiliano M. Portal
Cancers (2021) Vol. 13, Iss. 6, pp. 1380-1380
Open Access | Times Cited: 70
Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
Yang Zhao, Ena Oreskovic, Quanwei Zhang, et al.
Nature Immunology (2021) Vol. 22, Iss. 10, pp. 1219-1230
Open Access | Times Cited: 62
Mitogen signaling strength and duration can control cell cycle decisions
Ruth Nussinov, Wengang Zhang, Yonglan Liu, et al.
Science Advances (2024) Vol. 10, Iss. 27
Open Access | Times Cited: 14
A gene set enrichment analysis for the cancer hallmarks
Otília Menyhárt, William Kothalawala, Balázs Győrffy
Journal of Pharmaceutical Analysis (2024), pp. 101065-101065
Open Access | Times Cited: 10
Hypericin and its anticancer effects: From mechanism of action to potential therapeutic application
Neeraj Choudhary, Taylor E. Collignon, Devesh Tewari, et al.
Phytomedicine (2022) Vol. 105, pp. 154356-154356
Closed Access | Times Cited: 36
The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Jacob J. Adashek, Shumei Kato, Scott M. Lippman, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 46
The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers
Edgar Pérez‐Herrero, Alberto Fernández‐Medarde
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2243-2264
Open Access | Times Cited: 41
Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
Wei Geng, Zhilei Lv, Jinshuo Fan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 37
Machine learning methods for prediction of cancer driver genes: a survey paper
Renan Soares de Andrades, Mariana Recamonde‐Mendoza
Briefings in Bioinformatics (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 27
The Cell Transformation Assay: A Historical Assessment of Current Knowledge of Applications in an Integrated Approach to Testing and Assessment for Non-Genotoxic Carcinogens
Annamaria Colacci, Raffaella Corvi, Kyomi Ohmori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5659-5659
Open Access | Times Cited: 15
Single cell spatial biology over developmental time can decipher pediatric brain pathologies
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Neurobiology of Disease (2024) Vol. 199, pp. 106597-106597
Open Access | Times Cited: 5
Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning
Dazhi Lu, Yan Zheng, Xianyanling Yi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The theory of massively repeated evolution and full identifications of cancer-driving nucleotides (CDNs)
Lingjie Zhang, Tong Deng, Zhongqi Liufu, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 3
Inhibitory potentials of <i>Ageratum conyzoides</i> L. and <i>Tridax procumbens</i> L. ethanolic leaf extracts against multidrug-resistant bacteria (MDRB) from cancer patients
Oluwole O. Owoyemi, M. K. Oladunmoye
Journal of Clinical and Experimental Investigations (2025) Vol. 16, Iss. 2, pp. em00842-em00842
Closed Access
Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations
Sajal Dash, Nicholas A. Kinney, Robin Varghese, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Identifying modules of cooperating cancer drivers
Michael Klein, Vincent L. Cannataro, Jeffrey P. Townsend, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 3
Open Access | Times Cited: 22
Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
László Bányai, Mária Trexler, Krisztina Kerekes, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 21
Telomere function and regulation from mouse models to human ageing and disease
Corey Winston Jones-Weinert, Laura Mainz, Jan Karlseder
Nature Reviews Molecular Cell Biology (2024)
Closed Access | Times Cited: 3
Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
Refaat A. Eid, Muhammad Alaa Eldeen, Mohamed A. Soltan, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 7
The Risk Function of Breast and Ovarian Cancers in the Avrami–Dobrzyński Cellular Phase-Transition Model
Anna Zawadzka, B. Brzozowska, Anna Matyjanka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1352-1352
Open Access | Times Cited: 2
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data
Richard Norris, John R Jones, Erika J. Mancini, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Characterization of cancer-driving nucleotides (CDNs) across genes, cancer types, and patients
Lingjie Zhang, Tong Deng, Zhongqi Liufu, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2
On the discovered Cancer Driving Nucleotides (CDNs) –Distributions across genes, cancer types and patients
Lingjie Zhang, Tong Deng, Zhongqi Liufu, et al.
(2024)
Open Access | Times Cited: 2
The impact of genetic modifiers on variation in germline mutation rates within and among human populations
William Milligan, Guy Amster, Guy Sella
Genetics (2022) Vol. 221, Iss. 4
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top